Fused pyridine inhibitors of cGMP phosphodiesterase
US6326379A · kind A · utility
17Cited by
19References
23Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 10, 1999 |
| Grant date | Dec 4, 2001 |
| Priority date | — |
| Expiry date | Sep 10, 2019 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P43/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Compounds of the formulas ##STR1## are useful as inhibitors of cGMP PDE, especially type V.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.